The Hull University Teaching Hospitals NHS Trust operates in the city of Hull and the East Riding of Yorkshire, England. The Trust was formed on 1 October 1999 by the merger of the East Yorkshire Hospitals and the Royal Hull Hospitals National Health Service Trusts. It is based on two sites.

During the past decade, Hull University Teaching Hospitals NHS Trust conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 12 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 10 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hull University Teaching Hospitals NHS Trust" #1 sponsor was "Hull University Teaching Hospitals NHS Trust" with 18 trials, followed by "University of Hull" with 5 trials sponsored, "CymaBay Therapeutics, Inc." with 4 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "Medical Research Council" with 3 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hull University Teaching Hospitals NHS Trust" #1 collaborator was "National Institute for Health Research, United Kingdom" with 5 trials as a collaborator, "Hull University Teaching Hospitals NHS Trust" with 3 trials as a collaborator, "Barnsley Hospital NHS Foundation Trust" with 2 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 2 trials as a collaborator and "Guy's and St Thomas' NHS Foundation Trust" with 2 trials as a collaborator. Other collaborators include 107 different institutions and companies that were collaborators in the rest 106 trials.

According to Clinical.Site data, the most researched conditions in "Hull University Teaching Hospitals NHS Trust" are "COVID-19" (4 trials), "Breast Cancer" (3 trials), "Diabetic Foot" (3 trials), "Ovarian Cancer" (3 trials) and "Primary Biliary Cirrhosis" (3 trials). Many other conditions were trialed in "Hull University Teaching Hospitals NHS Trust" in a lesser frequency.

Most popular intervention types in "Hull University Teaching Hospitals NHS Trust" are "Drug" (48 trials), "Procedure" (19 trials), "Other" (17 trials), "Device" (12 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "adjuvant therapy" (5 trials), "radiation therapy" (5 trials), "capecitabine" (4 trials) and "cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hull University Teaching Hospitals NHS Trust" are 76 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Hull University Teaching Hospitals NHS Trust". 1 are not yet recruiting, 14 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Hull University Teaching Hospitals NHS Trust, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hull University Teaching Hospitals NHS Trust, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 23 trials that are defined as “Not Applicable".

Hull University Teaching Hospitals NHS Trust has several departments that took part in Clinical trials: "Castle Hill Hospital; The Queens Centre for Oncology and Haematology" - 12 trials, "Academic Vascular Surgery Unit, Vascular Laboratory, Alderson House, Hull Royal Infirmary" - 3 trials, "Academic Vascular Surgery Unit" - 2 trials